Deutsche Bank’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.78M Buy
411,834
+13,565
+3% +$230K ﹤0.01% 1135
2025
Q4
$5.33M Buy
398,269
+343,109
+622% +$4.25M ﹤0.01% 1275
2025
Q3
$650K Buy
55,160
+7,171
+15% +$66.9K ﹤0.01% 2417
2025
Q2
$311K Sell
47,989
-11,237
-19% -$73.9K ﹤0.01% 2709
2025
Q1
$346K Sell
59,226
-12,369
-17% -$88.6K ﹤0.01% 2676
2024
Q4
$498K Buy
71,595
+24,716
+53% +$170K ﹤0.01% 2614
2024
Q3
$267K Buy
46,879
+10,189
+28% +$70.9K ﹤0.01% 2775
2024
Q2
$265K Buy
36,690
+31,077
+554% +$272K ﹤0.01% 2662
2024
Q1
$52.8K Hold
5,613
﹤0.01% 3382
2023
Q4
$20.5K Hold
5,613
﹤0.01% 3489
2023
Q3
$17.6K Hold
5,613
﹤0.01% 3518
2023
Q2
$20K Sell
5,613
-2,408
-30% -$8.31K ﹤0.01% 3583
2023
Q1
$25.4K Sell
8,021
-2,368
-23% -$7.87K ﹤0.01% 3686
2022
Q4
$22.9K Hold
10,389
﹤0.01% 3754
2022
Q3
$37K Sell
10,389
-1,513
-13% -$14.5K ﹤0.01% 3667
2022
Q2
$115K Sell
11,902
-12,517
-51% -$158K ﹤0.01% 3458
2022
Q1
$406K Buy
24,419
+2,304
+10% +$40K ﹤0.01% 2873
2021
Q4
$458K Buy
22,115
+1,140
+5% +$36.4K ﹤0.01% 2904
2021
Q3
$732K Buy
20,975
+1,713
+9% +$74.1K ﹤0.01% 2805
2021
Q2
$997K Buy
+19,262
New +$1.01M ﹤0.01% 2771

Other funds holding DFTX

Deutsche Bank's DFTX Position: Q1 2026 in Review

Deutsche Bank increased its Definium Therapeutics (DFTX) stake by 3.4% in Q1 2026, buying an estimated $230K and bringing the position to 411,834 shares worth $7.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1135.

Deutsche Bank first reported a position in DFTX in Q2 2021 and has held it in 20 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Deutsche Bank held 411,834 shares of Definium Therapeutics worth $7.78M as of Q1 2026.
  • Deutsche Bank bought 13,565 Definium Therapeutics shares in Q1 2026, an estimated $230K.
  • Definium Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1135 holding.
  • Deutsche Bank first reported a position in Definium Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.